Dhampur Bio Organics Limited Earnings Summary — Q4 FY2026

• Dhampur Bio Organics reported a robust sequential profit growth of 170% in Q4 FY2026, reaching ₹46 Cr.
• Operating Profit Margin improved significantly from 9% in Q3 to 18% in Q4, signaling better cost control during the peak crushing season.
• Revenue grew 16.4% year-on-year, indicating a recovery in top-line momentum compared to the stagnant performance in previous quarters.
• Debt levels remain a concern with borrowings at ₹1,060 Cr, though the company managed to generate 177 Cr in Free Cash Flow for the full year.
• The board is scheduled to consider an interim dividend for FY 2026-27 in its upcoming July 2026 meeting.
• Inventory management showed improvement with days reducing to 231 compared to peaks of over 300 in prior years.

Management is focusing on pivoting toward high-potential 'Bio' and 'Organic' segments including ethanol and renewable power to counteract cyclical sugar volatility. They have recently initiated a proposal for a strategic acquisition of DBION Private Limited to bolster this transition.

Improving

After multiple quarters of losses or near-zero profits (Q1-Q2 FY2026), the strong Q4 performance and sharp margin recovery suggest a cyclical bottoming out.

The outlook remains cautiously optimistic as the company navigates regulatory shifts in ethanol pricing and high interest costs. The improvement in FCF and operating margins provides a buffer against its high debt exposure.